...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >EFFECT OF GUAR GUM AND XANTHAN GUM COMPRESSION COATING ON RELEASE STUDIES OF METRONIDAZOLE IN HUMAN FECAL MEDIA FOR COLON TARGETED DRUG DELIVERY SYSTEMS
【24h】

EFFECT OF GUAR GUM AND XANTHAN GUM COMPRESSION COATING ON RELEASE STUDIES OF METRONIDAZOLE IN HUMAN FECAL MEDIA FOR COLON TARGETED DRUG DELIVERY SYSTEMS

机译:瓜尔胶和黄原胶压缩涂层对结肠靶向药物输送系统人粪中甲硝唑释放的影响

获取原文

摘要

Objective: Compression coating with polysaccharides such as guar gum (GG) and xanthan gum (XG) mixture has been pioneer to be useful for microflora activated colon drug delivery systems. Method: In the present investigation bacteria triggered colon-targeted delivery of metronidazole (MTZ) was developed by compression coating with GG and XG in different coat weights. Rapidly disintegrating core tablets containing 100 mg of MTZ were prepared and compression coated with 150 mg, 250 mg and 350 mg of granules containing a mixture of GG and XG. Results: Drug release was highly retarded with 350 mg of coat weight, After 24 h of dissolution in human fecal media the cumulative percentage of drug release form the 350 mg compression coated tablets was found to be around 21.0±1.65%. As a result, the coat weight was further reduced to 250 mg. It was perceived that reduction in coat weight to 250 mg did not affect the initial drug release rate in simulated upper gastrointestinal tract (GIT) conditions, but at the end of the 24 h of dissolution the amount of drug release was increased to 84.8±1.22% in simulated human fecal media. On the other hand, 150 mg compression coated tablets showed 28.56±1.89% drug release in upper GIT, which indicates uncontrolled drug release within 5 h of the dissolution study. Conclusion: As a consequence, results of the present investigation shows that compression coated MTZ tablets with 250 mg of guar and xanthan gum coat is most likely to promise in exploiting the MTZ release in colon to treat amoebiasis and other local colonic diseases.
机译:目的:用瓜尔豆胶(GG)和黄原胶(XG)混合物等多糖进行压缩包衣一直是可用于微生物群激活的结肠给药系统的先驱。方法:在本研究中,通过用不同包衣量的GG和XG压缩包衣开发了细菌触发的甲硝唑(MTZ)靶向结肠的递送。制备包含100 mg MTZ的快速崩解核心片剂,并用150 mg,250 mg和350 mg包含GG和XG混合物的颗粒进行压制包衣。结果:350 mg包衣重药物释放被高度阻滞。在人粪便介质中溶解24 h后,从350 mg压缩包衣片剂中释放的累积百分数约为21.0±1.65%。结果,涂层重量进一步降低至250mg。可以认为,在模拟的上消化道(GIT)条件下,将衣壳重量减少至250 mg不会影响初始药物释放速率,但在溶出24小时后,药物释放量增加至84.8±1.22 %在模拟的人类粪便培养基中。另一方面,150 mg压缩包衣片剂在上GIT中显示28.56±1.89%的药物释放,这表明溶出度研究在5小时内药物释放不受控制。结论:因此,本研究结果表明,用250毫克瓜尔胶和黄原胶包衣的MTZ压制包衣片剂最有可能在利用结肠释放MTZ来治疗阿米巴病和其他局部结肠疾病中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号